The Protective Effect of HCV Cure on HCC Risk May be over-Estimated in Patients with Advanced Liver Disease

被引：0
|
作者：
Branch, Andrea D. [1 ]
Lewis, Sara [2 ]
Wyatt, Brooke [3 ]
Doyle, Erin [1 ]
Sung, Julie C. [3 ]
Misra, Suresh [4 ]
Eng, Francis [5 ]
Bosh, Ciara [5 ]
Friedman, Scott L. [6 ]
Dieterich, Douglas T. [3 ]
Aloman, Costica [3 ]
Branch-Elliman, Westyn [7 ,8 ]
Perumalswami, Ponni V. [3 ]
机构：
[1] ISMMS, Div Liver Dis, Dept Med, New York, NY USA
[2] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA
[3] ISMMS, New York, NY USA
[4] ISMMS, Dept Med, New York, NY USA
[5] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY 10029 USA
[6] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[7] VA Boston Healthcare Syst, Dept Med, Sect Infect Dis, Washington, DC USA
[8] Harvard Med Sch, Boston, MA USA
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
919
引用
收藏
页码：538A / 539A
页数：2
相关论文
共 50 条
  • [31] Disparities in Liver Fibrosis and HCC Risk in a Diverse Cohort of Racial/Ethnic Minority Patients with Liver Disease
    Kwon, Deukwo
    DeBose-Scarlett, Alexandra
    Yoneda, Masato
    Schiff, Eugene R.
    Thomas, Emmanuel
    HEPATOLOGY, 2018, 68 : 609A - 610A
  • [32] Individualization of HCC and Portal Hypertension Surveillance in Patients with Compensated Advanced Chronic Liver Disease and SVR
    Mattias Mandorfer
    Digestive Diseases and Sciences, 2023, 68 : 14 - 15
  • [33] Patients with HBV and HCV chronic liver disease under surveillance for HCC are diagnosed with pancreatic cancer at early stages
    Kumagi, Teru
    Terao, Takashi
    Yokota, Tomoyuki
    Azemoto, Nobuaki
    Uesugi, Kazuhiro
    Kisaka, Yoshiyasu
    Tanaka, Yoshinori
    Shibata, Naozumi
    Kuroda, Taira
    Koizumi, Mitsuhito
    Imamura, Yoshiki
    Ohno, Yoshinori
    Yukimoto, Atsushi
    Tange, Kazuhiro
    Nishiyama, Mari
    Miyata, Hideki
    Ishii, Hiroshi
    Hiasa, Yoichi
    HEPATOLOGY, 2016, 64 : 225A - 225A
  • [34] RISK OF HEPATIC DECOMPENSATION AND HCC IN PATIENTS WITH CIRRHOSIS SIGNIFICANTLY DIFFERS BY LIVER DISEASE ETIOLOGY
    Ng, Michelle
    Yekkaluri, Sruthi
    Quirk, Lisa
    Gopal, Purva
    Singal, Amit
    HEPATOLOGY, 2024, 80 : S1649 - S1650
  • [35] DYNAMIC CHANGES IN TRANSIENT ELASTOGRAPHY (TE) AND NON-INVASIVE MARKERS AFTER SUSTAINED VIROLOGICAL RESPONSE (SVR) IN HCV PATIENTS WITH COMPENSATED ADVANCED CHRONIC LIVER DISEASE (C-ACLD) MAY PREDICT LOW RISK OF HCC DEVELOPMENT.
    Alonso Lopez, Sonia
    Manzano Alonso, Maria Luisa
    Gea, Francisco
    Luisa Gutierrez, Maria
    Ahumada Jimenez, Adriana Maria
    Jose Devesa, Maria
    Olveira, Antonio
    Polo Lorduy, Benjamin Arturo
    Marquez, Laura
    Fernandez, Inmaculada
    Ruiz Cobo, Juan Carlos
    Rayon, Laura
    Riado, Daniel
    Izquierdo, Sonia
    Uson, Clara
    Real Martinez, Yolanda
    Rincon, Diego
    Fernandez-Rodriguez, Conrado M.
    Banares, Rafael
    HEPATOLOGY, 2019, 70 : 354A - 355A
  • [36] Dynamic of cytokine profiles predicts risk of HCC among HCV patients with advanced fibrosis after successful antiviral therapy
    Yu, Ming-Lung
    Lu, Ming-Ying
    Wang, Shu-Chi
    Yeh, Ming-Lun
    Huang, Chung-Feng
    Huang, Jee-Fu
    Dai, Chia-Yen
    Chuang, Wan-Long
    JOURNAL OF HEPATOLOGY, 2020, 73 : S611 - S612
  • [37] HCV treatment with DAA in patients listed for liver transplant does not result in an increased risk of HCC recurrence post-liver transplant
    Mazzarelli, C.
    Invernizzi, F.
    Suddle, A.
    Donato, M. F.
    Belli, L. S.
    Cannon, M. D.
    Marenco, S.
    Angrisani, D.
    Iavarone, M.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S117 - S118
  • [38] Stratification of Residual Risk of HCC Following HCV Clearance With Direct-Acting Antivirals in Patients With Advanced Fibrosis and Cirrhosis
    Setiawan, V. Wendy
    Rosen, Hugo R.
    HEPATOLOGY, 2020, 72 (06) : 1897 - 1899
  • [39] Cigarette smoking may aggravate liver disease in patients with hepatitis C virus (HCV) infection
    Elfert, A.
    Eldemerdash, T.
    Alhasanein, Y.
    Elnemr, T.
    AlMahdy, N.
    Almarhoomy, N.
    LIVER INTERNATIONAL, 2006, 26 : 44 - 44
  • [40] EFFECT OF PANCYTOPENIA AND LEUKOPENIA ON DISEASE PROGRESSION IN PATIENTS WITH ADVANCED LIVER DISEASE
    Boddie, Patrick
    Lymberopoulos, Peter
    Uddin, Anwar
    Tran, Vinh
    Salge, Madeleine Hines
    Shi, Michael
    Prasad, Pooja
    Goli, Karthik
    Shaikh, Anjiyah
    Samuel, Ronald
    Lee, Tzu-Hao
    Patidar, Kavish
    Cholankeril, George
    HEPATOLOGY, 2024, 80 : S1053 - S1053
12345